Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Other
This study will look at blood and tissue samples from people with and without a condition linked to a virus called the Epstein Barr virus (EBV).
The Epstein Barr virus is a common virus that most adults carry without noticing any effects. It usually infects cells of the immune system called B cells. But in some rare cases, the EB virus can infect other immune system cells called T cells and natural killer (NK) cells. This can cause rare types of lymphomas and leukaemias, including a non Hodgkin lymphoma which develops outside the lymphatic system (extra nodal), and a leukaemia called ‘aggressive natural killer cell leukaemia’.
Recruitment start: 1 February 2008
Recruitment end: 31 March 2021
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Claire Shannon-Lowe
Bloodwise
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Gregor Mackay Memorial Fund
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 06 Apr 2021
CRUK internal database number: 4059

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.